Search the Newsreel

Provident Financial Services, Inc $PFS Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. increased its stake in Provident Financial Services (NYSE:PFS) by 6.9% in the second quarter, now owning 998,562 shares valued at $23.6 million. Other institutional investors like Dimensional Fund Advisors LP, State Street Corp, and Wellington Management Group LLP also adjusted …

New Providence Acquisition III Ord Shs Class A (NPAC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Provident Financial Services (NYSE:PFS) Could Be A Buy For Its Upcoming Dividend

This article suggests that Provident Financial Services (NYSE:PFS) could be an attractive investment due to its upcoming dividend payment. The piece implies that investors looking for dividend income might consider buying shares in the company before the ex-dividend date.

Should You Buy Provident Financial Services, Inc. (NYSE:PFS) For Its Upcoming Dividend?

Provident Financial Holdings, Inc. (NASDAQ:PROV) Is About To Go Ex-Dividend, And It Pays A 3.1% Yield

Provident Financial Holdings, Inc. (NASDAQ:PROV) is set to go ex-dividend in three days, offering a 3.1% trailing yield from its annual dividend of US$0.56. While the company's 54% payout ratio suggests an affordable dividend, earnings per share have remained flat over the past five …

Provident Financial Holdings Inc (PROV) Earnings Forecast: Future EPS & Revenue Growth Estimates

"Biotech in the Balance" - Dr. Jeremy Levin, author and Chair of Ovid Therapeutics

Dr. Jeremy Levin, Chair of Ovid Therapeutics, discusses the critical balance between innovation and regulation in the biotech industry. He emphasizes the importance of rebuilding public trust through transparency and patient-centric approaches, while also addressing concerns about America's leadership in biotechnology amidst global competition …

Ovid Therapeutics Inc (OVID) News, Articles, Events & Latest Updates

This article compiles recent news and updates concerning Ovid Therapeutics Inc. (OVID), including earnings expectations, analyst ratings, and changes in short interest. Several reports discuss OVID's upcoming Q2 earnings, with Zacks suggesting they are not poised for a beat, while HC Wainwright issued positive …

Ovid Therapeutics Inc (OVID) Earnings Forecast: Future EPS & Revenue Growth Estimates

Ovid Therapeutics Inc (OVID) has an earnings forecast score of 9.00, placing it 17th out of 387 in the Biotechnology & Medical Research industry. Analysts have set an average price target of $5.00 for OVID, with a high of $7.00 and a low of …

Provident Financial (NYSE: PFS) grows profit as loans rise and nonaccruals increase

Provident Financial Holdings Inc (PROV) Stock News Today

Provident Financial Services, I (PFS) stock price, news, quote and history

This article provides a comprehensive overview of Provident Financial Services, Inc. (PFS) stock, including its current price, dividend information, historical performance, and key financial data. It also details the company's banking products, services, and recent analyst ratings, highlighting its position in the Regional Banks …

Should Provident’s New Risk and Accounting Leaders Reshape How Investors View PFS’s Earnings Quality?

Provident Financial (NASDAQ:PROV) Stock Passes Above 200 Day Moving Average - Time to Sell?

Provident Financial Holdings Inc (PROV) (Q4 2026) Earnings Call Highlights: Net Interest Margin ...

Provident Financial Holdings Inc (PROV) reported a 5% sequential increase in loan originations to $46.4 million for Q4 2026, alongside a net interest margin expansion of 8 basis points to 3.21%. Despite strong credit quality and shareholder returns, the company anticipates slowing net interest …

Janus Henderson Group PLC Takes $23.73 Million Position in Ovid Therapeutics $OVID

Janus Henderson Group PLC has acquired a significant new position in Ovid Therapeutics, purchasing 10.714 million shares valued at approximately $23.73 million, which gives them an 8.12% stake in the company. Institutional investors and hedge funds now collectively own 72.24% of OVID stock. Analyst …

Provident Financial Services And Provident Bank Appoint Former FDIC Examiner Michael E. Regan To Boards

Provident Financial Services and its subsidiary, Provident Bank, have appointed former FDIC Examiner Michael E. Regan to their boards of directors, effective July 30, 2026. Regan brings over 35 years of experience in financial institution supervision, corporate governance, regulatory compliance, and enterprise risk management …

Provident Financial (PFS) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of …

Earnings Preview: Ovid Therapeutics (OVID) Q2 Earnings Expected to Decline

Ovid Therapeutics (OVID) is projected to report a year-over-year decline in Q2 2026 earnings, with a consensus estimate of a $0.10 per share loss and revenues of $0.15 million. Despite carrying a Zacks Rank #2, the company's Earnings ESP of -6.94% suggests it may …

Ovid Therapeutics Inc. (OVID) Stock Price, News, Quote & History

Ovid Therapeutics Inc. (OVID) stock closed at $2.62, up 3.15%, with after-hours trading showing a further increase. The biopharmaceutical company focuses on developing small molecule medicines for brain disorders, including epilepsies and seizure-related neurological disorders. The company has several drugs in Phase 1 clinical …

Ovid Therapeutics (OVID) Expected to Release Quarterly Earnings on Wednesday

Provident Financial Holdings (PROV) Gains 0.61% as Regional Bank Stock Holds Above Key Support - Triangle Correction

Provident Financial Services appoints Michael Regan to board

Provident Financial Services, Inc. (NYSE:PFS) has appointed Michael E. Regan to its boards of directors, and that of its subsidiary Provident Bank, effective July 30, 2026. Regan brings over 35 years of financial regulation experience from his career at the Federal Deposit Insurance Corporation …

Provident Financial (NYSE: PFS) adds board member, promotes chief accountant

Provident Financial Services, Inc. (NYSE: PFS) has announced significant leadership changes. Michael E. Regan has been elected to the boards of the company and Provident Bank as a Class of 2028 director, expanding both boards from 12 to 13 directors. Additionally, Diane Gigliotti has …

Provident Financial Services adds Michael E. Regan to board; Diane Gigliotti named Chief Accounting Officer

Provident Financial Services has elected Michael E. Regan to its board of directors and appointed Diane Gigliotti as Senior Vice President and Chief Accounting Officer, both effective July 30, 2026. Michael E. Regan will also join several committees, and the company's board has expanded …

Provident Financial Services, Inc. and Provident Bank Promote Diane Gigliotti to Senior Vice President, Chief Accounting Officer

Diane Gigliotti has been promoted to Senior Vice President, Chief Accounting Officer at Provident Financial Services, Inc. and Provident Bank. In this expanded role, she will oversee the company's accounting function, financial reporting, regulatory compliance, and serve as a strategic advisor. Gigliotti brings over …

Provident Financial Appoints New Board Member

Provident Financial Services has appointed Michael E. Regan to its board and that of Provident Bank, effective July 30, 2026. Regan brings over 35 years of regulatory experience from the FDIC, which is expected to enhance the company's governance, risk management, and strategic execution. …

Provident Bank appoints Michael E. Regan to its boards for his regulatory expertise.

Provident Financial Services, Inc. and its subsidiary Provident Bank have appointed Michael E. Regan to their boards of directors. Regan brings over 35 years of experience in financial regulation, having worked extensively with the FDIC. His expertise is expected to enhance Provident's governance and …

Provident boards gain more than 35 years of oversight experience

Provident Financial Services (NYSE: PFS) and Provident Bank have appointed Michael E. Regan to their boards of directors, effective July 30, 2026. Regan brings over 35 years of experience as a financial regulatory executive with the FDIC, where he oversaw safety, soundness, governance, and …

Precision Trading with Provident Financial Holdings Inc. (PROV) Risk Zones

This article from Stock Traders Daily outlines a precision trading analysis for Provident Financial Holdings Inc. (PROV), highlighting strong sentiment across all horizons and compelling upside potential due to the absence of resistance levels above the current price. It presents three AI-generated trading strategies—Position …

Provident Financial Services (NYSE:PFS) Earns Outperform Rating from Keefe, Bruyette & Woods

Keefe, Bruyette & Woods reaffirmed its "outperform" rating for Provident Financial Services (NYSE:PFS) and raised its price target from $26 to $28, signaling an 11.44% potential upside. Other analysts like Hovde Group, DA Davidson, and Piper Sandler have also issued positive reports, contributing to …

OVID THERAPEUTICS INC. : OPPENHEIMER RAISES TARGET PRICE TO $9 FROM $7

Oppenheimer has increased its target price for OVID Therapeutics Inc. (OVID.O) from $7 to $9. This update reflects an analyst's revised valuation for the pharmaceutical company. The article, sourced from Reuters, provides this specific financial news without further detail.

Why Prairie Provident Resources Inc stock surged yesterday

Provident Financial Services: Moderate Upside Given Potential Credit Resolution (NYSE:PFS)

Provident Financial Services (PFS) Earnings Strength Keeps Valuation In Focus

Provident Financial Services (PFS) reported strong quarterly revenue and a 17% EPS increase, leading to a recent share price surge. While its P/E ratio suggests it's undervalued compared to peers and fair value estimates, its discounted cash flow (DCF) model indicates an even steeper …

Provident Financial Services, Inc $PFS Stock Holdings Raised by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership significantly increased its stake in Provident Financial Services (NYSE:PFS) by 82% in the first quarter, now holding 341,162 shares valued at approximately $7.2 million. This increase comes amid positive analyst sentiment, with several firms raising price targets after PFS beat …